Bayer introduces medication for chronic kidney disease


PTI, Aug 26, 2022, 11:38 AM IST

Credit: iStock Photo

Drugmaker Bayer on Thursday said it has introduced a medication for the treatment of chronic kidney disease associated with diabetes under the brand name Kerendia.

The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease associated with type 2 diabetes.

“The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. Despite therapy, these patients often progress to kidney failure.

“Finerenone (Kerendia) therefore offers a new treatment approach for these vulnerable patients to slow down the progression of chronic kidney disease and reduce the risk of kidney failure,” Bayer Zydus Pharma Managing Director Manoj Saxena said in a statement.

Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease in India.

Around seventy-four million people suffer from diabetes in the country and this figure is likely to increase to ninety-three million by 2030.

The number of people with diabetes in India is the second highest in the world, after China.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Balasore tragedy result of composite negligence of railway officials: Orissa High Court

Actress Kasthuri stokes controversy by her remarks on Telugu-speaking people in TN

Three convicted for 2016 Kollam collectorate blast case

Expect Canadian government to ensure justice, uphold rule of law: PM Modi

Lone tusker spotted on NH-166 near Karkala, disrupts traffic

Lokayukta police summon Karnataka CM Siddaramaiah for questioning in MUDA case on Wednesday

Not ‘kaun banega mukhyamantri’ contest; MVA to name CM pick after polls: Jairam Ramesh

Related Articles More

Risk of abnormal blood fat levels increased by about 30 pc during pandemic, finds study

Attention problems could be ‘middleman’ between genetic risk for, experiencing psychosis: Study

Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study

Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study

Study finds loss of smell linked with inflammation in 140 conditions, could be early sign of disease

MUST WATCH

Gho Pooja in Deepavali Festival

Melukote Deepavali

Ganapathi Co-operative Society Ltd

Udayavani Chinnara Banna 2024

Annapoorna Aahar | Food Places In Mysore


Latest Additions

Balasore tragedy result of composite negligence of railway officials: Orissa High Court

Actress Kasthuri stokes controversy by her remarks on Telugu-speaking people in TN

Three convicted for 2016 Kollam collectorate blast case

Expect Canadian government to ensure justice, uphold rule of law: PM Modi

Group clash in Indore after argument over bursting firecrackers: NSA slapped against 2 accused

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.